A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
Public ClinicalTrials.gov record NCT02544763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Randomized, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P, CBD) as Add-on Therapy in Patients With Tuberous Sclerosis Complex Who Experience Inadequately-controlled Seizures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The blinded phase only will be described in this record. Participants will receive 1 of 2 doses of GWP42003-P or matching placebo. The primary clinical hypothesis is that there will be a difference between GWP42003-P and placebo in their effect on seizure frequency.
Study identification
- NCT ID
- NCT02544763
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 1 Year to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 5, 2016
- Primary completion
- Jan 21, 2019
- Completion
- Feb 25, 2019
- Last update posted
- Sep 27, 2022
2016 – 2019
United States locations
- U.S. sites
- 23
- U.S. states
- 19
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Epilepsy Center | Birmingham | Alabama | 35294 | — |
| Arkansas Children's Hospital | Little Rock | Arkansas | 72202 | — |
| UCLA-Pediatric Neurology | Los Angeles | California | 90095 | — |
| UCSF Benioff Children's Hospital Oakland | Oakland | California | 94609 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Pediatric Neurology | Miami | Florida | 33155 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Mid Atlantic Epilepsy & Sleep Centre | Bethesda | Maryland | 20817 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Minnesota Epilepsy Group, P.A | Saint Paul | Minnesota | 55102 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| NYU Comprehensive Epilepsy Center | New York | New York | 10016 | — |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | — |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| WellSpan Paediatric Neurology | Manchester | Pennsylvania | 17345 | — |
| Le Bonheur Children's Hospital | Memphis | Tennessee | 38103 | — |
| Texas Scottish Rite Hospital for Children | Dallas | Texas | 75104 | — |
| Cook Children's Health Care System | Fort Worth | Texas | 76104 | — |
| Paediatric Neurology | Salt Lake City | Utah | 84113 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
| Seattle Children's Hospital | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02544763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 27, 2022 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02544763 live on ClinicalTrials.gov.